Suppliers / PharmaZell(India)PrivateLimited

PharmaZell(India)PrivateLimited

India Updated 9 July 2026

The public registers hold a second record for PharmaZell(India)PrivateLimited. The fuller profile, with 9 active US DMFs and 12 valid CEPs, is at PharmaZell. Figures on this page cover only this record.

PharmaZell(India)PrivateLimited is an API manufacturer based in India.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Ｌ‐カルボシステイン PMDA (Japan) 2
Atenolol PMDA (Japan) 1
Mesalazine PMDA (Japan) 1
「日局」Ｌ－カルボシステイン（製造専用） PMDA (Japan) 1

Also appears on these molecule pages

Atenolol API Mesalamine API

Questions about PharmaZell(India)PrivateLimited

What does PharmaZell(India)PrivateLimited make?
4 molecules are on record against PharmaZell(India)PrivateLimited, including Ｌ‐カルボシステイン, Atenolol, Mesalazine and 「日局」Ｌ－カルボシステイン（製造専用）. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. PharmaZell(India)PrivateLimited comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Zydus Lifesciences shares 1 molecule Ipca Laboratories shares 1 molecule Societa Italiana Medicinali Scandicci Sims shares 1 molecule Kopran shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability